Children of God for Life announced today the stunning news that PepsiCo will not use aborted fetal cell line HEK-293 (human embryonic kidney) in their contractual agreement with Senomyx to develop flavor enhancers for their beverages.
Children of God for Life’s Executive Director, Debi Vinnedge, hailed PepsiCo’s decision as a major breakthrough and achievement by thousands of concerned consumers who have been writing and boycotting PepsiCo beverages since last May.
In a letter to Children of God for Life, PepsiCo’s VP of Global Public Policy, Paul Boykas stated that “Senomyx will not use HEK cells or any other tissues or cell lines derived from human embryos or fetuses for research performed on behalf of PepsiCo.”
“We are absolutely thrilled with PepsiCo’s decision,” stated Mrs. Vinnedge. “They have listened to their customers and have made both a wise and profound statement of corporate integrity that deserves the utmost respect, admiration and support of the public.”
In speaking with Mr. Boykas, Vinnedge noted that the company had conducted internal discussions, recognizing it was a highly sensitive and controversial subject that quite frankly, was not in the best interests of PepsiCo.
“We took the matter very seriously,” stated Mr. Boykas. “We have an official Statement on Responsible Research and we intend to live by that policy.” [Source]
That is good news, but just last month they said:
Jeff Dahncke, PepsiCo senior director for communications, thanked The Washington Times in an email for “giving us the opportunity to clarify misperceptions and erroneous media reports on the topic.”
“PepsiCo does not conduct or fund research, including research performed by third parties, that utilizes any human tissue or cell lines derived from embryos or fetuses. We clearly communicate this in our Responsible Research Statement on our website,” Dahncke told the newspaper. “Any research funded by PepsiCo and conducted by Senomyx for PepsiCo must abide by this responsible research statement.”